Establishing Patient Registries for Rare Diseases: Rationale and Challenges

被引:72
作者
Boulanger, Vanessa [1 ]
Schlemmer, Marissa [1 ]
Rossov, Suzanne [1 ]
Seebald, Allison [1 ]
Gavin, Pamela [1 ]
机构
[1] Natl Org Rare Disorders, 55 Kenosia Ave, Danbury, CT 06810 USA
关键词
D O I
10.1007/s40290-020-00332-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Globally, an estimated 350 million people are affected by a rare disease diagnosis. Knowledge limitations persist for the majority of rare conditions due to systemic and structural challenges in healthcare and research. Disease-specific patient populations are often small and geographically dispersed; funding support for research is restricted; and diagnostic delays are common due to disease complexities, limited medical training for practitioners, and evolving foundational knowledge related to disease characterization. Patient registries can be effective, convenient, and cost-efficient tools to support documentation of the natural history of a disease, centering patients as research partners in the process while uniting rare communities around a common initiative. Current global trends towards innovative and patient-centered healthcare are enabling patient registries to increasingly emerge as valuable tools for use within rare disease research and drug development. This article describes the value of and rationale for establishing rare disease patient registries and the considerations and challenges that stakeholders, such as researchers, industry, health care providers, and patient community organizations, may encounter.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 38 条
  • [1] [Anonymous], 2019, ALS NEWS
  • [2] [Anonymous], 2020, STRATEGIC PLAN
  • [3] Clinical Trials in Rare Disease: Challenges and Opportunities
    Augustine, Erika F.
    Adams, Heather R.
    Mink, Jonathan W.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2013, 28 (09) : 1142 - 1150
  • [4] Dispelling myths about rare disease registry system development
    Bellgard, Matthew
    Beroud, Christophe
    Parkinson, Kay
    Harris, Tess
    Ayme, Segolene
    Baynam, Gareth
    Weeramanthri, Tarun
    Dawkins, Hugh
    Hunter, Adam
    [J]. SOURCE CODE FOR BIOLOGY AND MEDICINE, 2013, 8 (01):
  • [5] Bringing Big Data to Personalized Healthcare: A Patient-Centered Framework
    Chawla, Nitesh V.
    Davis, Darcy A.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S660 - S665
  • [6] Comet Initiative, Core outcome measures in effectiveness trials
  • [7] COSMIN, COSMIN IN
  • [8] Critical Path Institute, 2019, FUND FDA C PATH NORD
  • [9] Creating an effective clinical registry for rare diseases
    D'Agnolo, Hedwig M. A.
    Kievit, Wietske
    Andrade, Raul J.
    Karlsen, Tom Hemming
    Wedemeyer, Heiner
    Drenth, Joost P. H.
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) : 333 - 338
  • [10] The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks
    Evangelista, Teresinha
    Hedley, Victoria
    Atalaia, Antonio
    Johnson, Matt
    Lynn, Stephen
    Le Cam, Yann
    Bushby, Kate
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11